Close this search box.

by Amanda Conschafter, blog editor

As state legislatures gear up for the new year, several have introduced legislation aimed at accessible, safe medications.

The organization notes that specialty tier drugs, sometimes needed for rare or chronic illnesses, sometimes come with exorbitant co-insurance rates. Patient who cannot afford their out-of-pocket costs are effectively priced out of the care they need.

The bill aims to reinforce the Affordable Care Act’s vision of informed, empowered patients selecting the health insurance coverage that’s best for them.

The Alliance for Patient Access submitted a letter of support to legislators on behalf of its Colorado members. AfPA noted that “the legislation contains the patient safety principles that AfPA member physicians have identified as critical for safe access to biosimilar medications and is worthy of [legislators’] support.”

Georgia, Texas and several other states also have substitution bills pending. Legislators may be spurred to action by the Food and Drug Administration’s recent recommendation for approval of the first U.S. biosimilar.

Leave a Reply

Your email address will not be published. Required fields are marked *